Table of Contents Author Guidelines Submit a Manuscript
Tuberculosis Research and Treatment
Volume 2010, Article ID 406346, 6 pages
Clinical Study

The Soluble Plasminogen Activator Receptor as a Biomarker on Monitoring the Therapy Progress of Pulmonary TB-AFB(+) Patients

1Laboratory of Biochemistry-Molecular Biology, Faculty of Medicine, Brawijaya University, Malang 65145, Indonesia
2Department of Pulmonology, Faculty of Medicine, Brawijaya University Malang-Dr. Saiful Anwar Hospital Malang, Malang 65145, Indonesia

Received 29 June 2010; Accepted 8 September 2010

Academic Editor: William N. Rom

Copyright ยฉ 2010 Tri Yudani Mardining Raras and Iin Noor Chozin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [3 citations]

The following is the list of published articles that have cited the current article.

  • Tri Yudani Mardining Raras, Triwahju Astuti, and Iin Noor Chozin, “Soluble Urokinase Plasminogen Activator Receptor Levels in Tuberculosis Patients at High Risk for Multidrug Resistance,” Tuberculosis Research and Treatment, vol. 2012, pp. 1–5, 2012. View at Publisher ยท View at Google Scholar
  • Junaid Shaik, Manormoney Pillay, and Prakash Jeena, “The role of interferon gamma release assays in the monitoring of response to anti-tuberculosis treatment in children,” Paediatric Respiratory Reviews, 2013. View at Publisher ยท View at Google Scholar
  • Ummugulsum Can, Asuman Guzelant, Fatma Humeyra Yerlikaya, and Sebnem Yosunkaya, “The Role of Serum Soluble Urokinase-Type Plasminogen Activator Receptor in Stable Chronic Obstructive Pulmonary Disease,” Journal of Investigative Medicine, vol. 62, no. 7, pp. 938–943, 2014. View at Publisher ยท View at Google Scholar